Beneficial Cardiovascular Pleiotropic Effects of Statins
Top Cited Papers
- 15 June 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (23_suppl_1) , III-39-III-43
- https://doi.org/10.1161/01.cir.0000131517.20177.5a
Abstract
Pleiotropic effects of a drug are actions other than those for which the agent was specifically developed. These effects may be related or unrelated to the primary mechanism of action of the drug, and they are usually unanticipated. Pleiotropic effects may be undesirable (such as side effects or toxicity), neutral, or, as is especially the case with HMG-CoA reductase inhibitors (statins), beneficial. Pleiotropic effects of statins include improvement of endothelial dysfunction, increased nitric oxide bioavailability, antioxidant properties, inhibition of inflammatory responses, and stabilization of atherosclerotic plaques. These and several other emergent properties could act in concert with the potent low-density lipoprotein cholesterol-lowering effects of statins to exert early as well as lasting cardiovascular protective effects. Understanding the pleiotropic effects of statins is important to optimize their use in treatment and prevention of cardiovascular disease.Keywords
This publication has 58 references indexed in Scilit:
- Simvastatin Lowers C-Reactive Protein Within 14 DaysCirculation, 2002
- Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial FunctionCirculation, 2002
- Atorvastatin Lowers C-Reactive Protein and Improves Endothelium-Dependent Vasodilation in Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2002
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?Trends in Cardiovascular Medicine, 2001
- Esterified Cholesterol Accumulation Induced by Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells Is Reduced by HMG-CoA Reductase InhibitorsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery diseaseThe American Journal of Cardiology, 1995
- Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993